Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Vibrio cholerae O1 and O139 surface antigens are carbohydrate structures located on the outer membrane of the bacterium Vibrio cholerae, forming the O-antigenic portion of its lipopolysaccharide (LPS)[1][4]. These antigens define the two main epidemic serogroups, O1 and O139, that cause all global pandemics and large outbreaks of cholera, a severe diarrheal disease[1][6]. The O1 antigen is a homopolymer of perosamine sugars, while the O139 antigen is chemically distinct and also associated with a polysaccharide capsule[1][6]. They are essential virulence and immune determinants, required for colonization, immune evasion, and survival, and are principal targets for both natural immune responses and cholera vaccines[2][4]. Antigenic phase variation can modulate expression of these antigens, promoting bacterial persistence and occasionally reducing vaccine efficacy[2]. Both antigens are diagnostic and vaccine targets; antibodies elicited against them can provide strain-specific protection[2][4].
Induction of adaptive immune response (production of O1/O139-specific antibodies to neutralize and clear V. cholerae); Inhibition of colonization and infection by blocking antigen attachment to host tissues; Bacteriophage therapy (some phages specifically target O1 antigen for attachment and lysis)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vibrio cholerae O1 and O139 surface antigen.